-
公开(公告)号:US20230122911A1
公开(公告)日:2023-04-20
申请号:US17985220
申请日:2022-11-11
发明人: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC分类号: A61K9/20 , C07D233/86 , A61K9/10 , A61K31/4166 , A61K47/32 , A61K47/38 , A61K9/16 , A61K31/4164
摘要: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号:US11839689B2
公开(公告)日:2023-12-12
申请号:US17985235
申请日:2022-11-11
发明人: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC分类号: A61K9/20 , C07D233/86 , A61K9/10 , A61K31/4166 , A61K47/32 , A61K47/38 , A61K9/16 , A61K31/4164
CPC分类号: A61K9/2054 , A61K9/10 , A61K9/16 , A61K9/1652 , A61K9/2095 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
摘要: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号:US20190209476A1
公开(公告)日:2019-07-11
申请号:US16044255
申请日:2018-07-24
发明人: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC分类号: A61K9/20 , C07D233/86 , A61K47/38 , A61K47/32 , A61K31/4166 , A61K9/16 , A61K31/4164 , A61K9/10
CPC分类号: A61K9/2054 , A61K9/10 , A61K9/16 , A61K9/1652 , A61K9/2095 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
摘要: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号:US20230210778A1
公开(公告)日:2023-07-06
申请号:US17985235
申请日:2022-11-11
发明人: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC分类号: A61K9/20 , C07D233/86 , A61K9/10 , A61K31/4166 , A61K47/32 , A61K47/38 , A61K9/16 , A61K31/4164
CPC分类号: A61K9/2054 , C07D233/86 , A61K9/10 , A61K31/4166 , A61K47/32 , A61K47/38 , A61K9/16 , A61K9/1652 , A61K9/2095 , A61K31/4164
摘要: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号:US20200060976A1
公开(公告)日:2020-02-27
申请号:US16371618
申请日:2019-04-01
发明人: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC分类号: A61K9/20 , C07D233/86 , A61K9/10 , A61K31/4166 , A61K47/32 , A61K47/38 , A61K9/16 , A61K31/4164
摘要: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号:US20140179749A1
公开(公告)日:2014-06-26
申请号:US14023878
申请日:2013-09-11
发明人: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC分类号: A61K9/16 , A61K9/20 , A61K31/4164
CPC分类号: A61K9/2054 , A61K9/10 , A61K9/16 , A61K9/1652 , A61K9/2095 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
摘要: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号:US12097189B1
公开(公告)日:2024-09-24
申请号:US18613281
申请日:2024-03-22
申请人: ASTELLAS PHARMA INC.
发明人: Yuuki Takaishi , Soichiro Nakamura , Yutaka Takahashi , Takashi Nishizato , Daisuke Murayama , Emiko Murayama , Kazuhiro Sako
CPC分类号: A61K31/426 , A61K9/0004 , A61K9/1652 , A61K9/2031 , A61K9/205 , A61K9/2054 , A61K9/2072 , A61K9/2086 , A61K9/2846 , A61K9/2866 , A61K47/36
摘要: A pharmaceutical composition for modified release comprising (R)-2-(2-aminothiazol-4-yl)-4′-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a maximum blood drug concentration (Cmax) when administered in fasted state is 400 ng/ml or less, is disclosed.
-
公开(公告)号:US20140100256A1
公开(公告)日:2014-04-10
申请号:US14023637
申请日:2013-09-11
发明人: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC分类号: A61K31/4166 , A61K9/10 , A61K47/32 , A61K47/38
CPC分类号: A61K9/2054 , A61K9/10 , A61K9/16 , A61K9/1652 , A61K9/2095 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
摘要: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
摘要翻译: 本公开提供了恩扎洛胺的制剂及其用于治疗过度增殖性疾病的用途。
-
公开(公告)号:US20170224624A1
公开(公告)日:2017-08-10
申请号:US15267352
申请日:2016-09-16
发明人: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC分类号: A61K9/20 , A61K9/10 , C07D233/86
CPC分类号: A61K9/2054 , A61K9/10 , A61K9/16 , A61K9/1652 , A61K9/2095 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
摘要: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号:US20140378517A1
公开(公告)日:2014-12-25
申请号:US14481986
申请日:2014-09-10
发明人: Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC分类号: A61K31/4166 , A61K9/20 , A61K47/38
CPC分类号: A61K9/2054 , A61K9/10 , A61K9/16 , A61K9/1652 , A61K9/2095 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
摘要: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
-
-
-
-
-
-
-
-